AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 133 filers reported holding AKEBIA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $173,000 | -46.8% | 76,324 | -20.5% | 0.02% | -48.6% |
| Q1 2021 | $325,000 | +550.0% | 96,016 | +438.4% | 0.04% | +362.5% |
| Q4 2020 | $50,000 | -74.9% | 17,833 | -77.5% | 0.01% | -75.0% |
| Q3 2020 | $199,000 | +40.1% | 79,240 | +321.8% | 0.03% | +14.3% |
| Q1 2020 | $142,000 | -34.0% | 18,787 | -51.5% | 0.03% | -24.3% |
| Q4 2018 | $215,000 | +121.6% | 38,767 | +252.8% | 0.04% | +184.6% |
| Q3 2018 | $97,000 | -73.4% | 10,989 | -69.9% | 0.01% | -76.4% |
| Q2 2018 | $365,000 | +50.2% | 36,534 | +43.0% | 0.06% | +52.8% |
| Q1 2018 | $243,000 | -41.4% | 25,556 | +21.0% | 0.04% | -46.3% |
| Q3 2017 | $415,000 | +174.8% | 21,115 | +45.4% | 0.07% | +63.4% |
| Q4 2016 | $151,000 | +2.7% | 14,518 | -26.0% | 0.04% | +2.5% |
| Q2 2016 | $147,000 | – | 19,629 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $3,340,000 | 5.66% |
| Orchard Capital Management, LLC | 1,762,731 | $1,265,000 | 0.36% |
| Ikarian Capital, LLC | 1,200,000 | $860,000 | 0.11% |
| Ikarian Capital, LLC | 800,000 | $575,000 | 0.08% |
| XTX Topco Ltd | 102,392 | $74,000 | 0.03% |
| Nantahala Capital Management | 965,800 | $693,000 | 0.03% |
| Worth Venture Partners, LLC | 63,500 | $46,000 | 0.02% |
| Ardent Capital Management, Inc. | 43,429 | $31,000 | 0.02% |
| Virtus ETF Advisers LLC | 65,149 | $47,000 | 0.02% |
| RICE HALL JAMES & ASSOCIATES, LLC | 513,292 | $368,000 | 0.02% |